Dec 31, 2014

ANI Pharmaceuticals Q4 2014 Earnings Report

Total Revenue
$21M
Previous year: $10.5M
+99.7%
EPS
$1.94
Previous year: $0.35
+454.3%
Gross Profit
$17.4M
Previous year: $7.85M
+121.3%
Cash and Equivalents
$169M
Previous year: $11.1M
+1422.2%
Free Cash Flow
$10.4M
Previous year: -$2.89M
-459.4%
Total Assets
$260M
Previous year: $44.5M
+483.3%

ANI Pharmaceuticals

ANI Pharmaceuticals